ReiThera Srl   Report issue

For profit Phase 1 Phase 3
Founded: Roma Italy (2013)

Organization Overview

First Clinical Trial
2013
NCT01070407
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

ReiThera Srl